Amarna Therapeutics
Guillaume is the CFO of the Netherlands based MercachemSyncom, a leading European mid-sized contract research organization. Guillaume is a seasoned senior biotech executive, that has been working in the healthcare industry for most of his career. He held positions at Merck, Sharpe & Dohme, as well as served as Chief Financial Officer (CFO) of Wolters Kluwer Health. He also worked as CFO for Galapagos between 2009 and 2014.
Guillaume holds a master’s degree in Economics from the University of Maastricht, Netherlands and is a Certified Registered Accountant.
This person is not in the org chart
This person is not in any offices